713 related articles for article (PubMed ID: 32025388)
1. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
[TBL] [Abstract][Full Text] [Related]
2. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
[TBL] [Abstract][Full Text] [Related]
3. Real-time motion-including dose estimation of simulated multi-leaf collimator-tracked magnetic resonance-guided radiotherapy.
Persson E; Goodwin E; Eiben B; Wetscherek A; Nill S; Oelfke U
Med Phys; 2024 Mar; 51(3):2221-2229. PubMed ID: 37898109
[TBL] [Abstract][Full Text] [Related]
4. Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System.
Feldman AM; Modh A; Glide-Hurst C; Chetty IJ; Movsas B
Cureus; 2019 Sep; 11(9):e5774. PubMed ID: 31723533
[TBL] [Abstract][Full Text] [Related]
5. First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany.
Klüter S; Katayama S; Spindeldreier CK; Koerber SA; Major G; Alber M; Akbaba S; Debus J; Hörner-Rieber J
Strahlenther Onkol; 2020 Aug; 196(8):691-698. PubMed ID: 32002567
[TBL] [Abstract][Full Text] [Related]
6. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric Feasibility of Utilizing the ViewRay Magnetic Resonance Guided Linac System for Image-guided Spine Stereotactic Body Radiation Therapy.
Redler G; Stevens T; Cammin J; Malin M; Green O; Mutic S; Pitroda S; Aydogan B
Cureus; 2019 Dec; 11(12):e6364. PubMed ID: 31938646
[TBL] [Abstract][Full Text] [Related]
8. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
9. MRI-Guided Online Adaptive Stereotactic Body Radiation Therapy of Liver and Pancreas Tumors on an MR-Linac System.
Stanescu T; Shessel A; Carpino-Rocca C; Taylor E; Semeniuk O; Li W; Barry A; Lukovic J; Dawson L; Hosni A
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158984
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
[TBL] [Abstract][Full Text] [Related]
11. Experimental demonstration of real-time cardiac physiology-based radiotherapy gating for improved cardiac radioablation on an MR-linac.
Akdag O; Borman PTS; Mandija S; Woodhead PL; Uijtewaal P; Raaymakers BW; Fast MF
Med Phys; 2024 Apr; 51(4):2354-2366. PubMed ID: 38477841
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
[TBL] [Abstract][Full Text] [Related]
13. Characterization of positional accuracy of a double-focused and double-stack multileaf collimator on an MR-guided radiotherapy (MRgRT) Linac using an IC-profiler array.
Mittauer KE; Yadav P; Paliwal B; Bayouth JE
Med Phys; 2020 Feb; 47(2):317-330. PubMed ID: 31682018
[TBL] [Abstract][Full Text] [Related]
14. Technical note: Toward implementation of MR-guided radiation therapy for laryngeal cancer with healthy volunteer imaging and a custom MR-CT larynx phantom.
Huynh E; Boyle S; Campbell J; Penney J; Mak RH; Schoenfeld JD; Leeman JE; Williams CL
Med Phys; 2022 Mar; 49(3):1814-1821. PubMed ID: 35090060
[TBL] [Abstract][Full Text] [Related]
15. Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer.
Wahlstedt I; Andratschke N; Behrens CP; Ehrbar S; Gabryś HS; Schüler HG; Guckenberger M; Smith AG; Tanadini-Lang S; Tascón-Vidarte JD; Vogelius IR; van Timmeren JE
Radiother Oncol; 2022 May; 170():205-212. PubMed ID: 35351536
[TBL] [Abstract][Full Text] [Related]
16. Quantifying Intrafraction Motion and the Impact of Gating for Magnetic Resonance Imaging-Guided Stereotactic Radiation therapy for Prostate Cancer: Analysis of the Magnetic Resonance Imaging Arm From the MIRAGE Phase 3 Randomized Trial.
Neylon J; Ma TM; Savjani R; Low DA; Steinberg ML; Lamb JM; Nickols NG; Kishan AU; Cao M
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1181-1191. PubMed ID: 38160916
[TBL] [Abstract][Full Text] [Related]
17. Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
Hall WA; Straza MW; Chen X; Mickevicius N; Erickson B; Schultz C; Awan M; Ahunbay E; Li XA; Paulson ES
PLoS One; 2020; 15(8):e0236570. PubMed ID: 32764748
[TBL] [Abstract][Full Text] [Related]
18. A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).
Wolfe S; Diven MA; Marciscano AE; Zhou XK; Kishan AU; Steinberg ML; Miccio JA; Camilleri P; Nagar H
BMC Cancer; 2023 Sep; 23(1):923. PubMed ID: 37777738
[TBL] [Abstract][Full Text] [Related]
19. Time Analysis of Online Adaptive Magnetic Resonance-Guided Radiation Therapy Workflow According to Anatomical Sites.
Güngör G; Serbez İ; Temur B; Gür G; Kayalılar N; Mustafayev TZ; Korkmaz L; Aydın G; Yapıcı B; Atalar B; Özyar E
Pract Radiat Oncol; 2021; 11(1):e11-e21. PubMed ID: 32739438
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy.
Hall MD; Mittauer KE; Herrera R; Von Werne K; Kotecha R; Kalman NS; McCulloch J; Alvarez D; McAllister NC; Doty DG; Rzepczynski AE; Deere W; Gutierrez AN; Chuong MD
Front Oncol; 2022; 12():1037674. PubMed ID: 36713501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
